Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Elliott Takes Big Stake in Drugmaker Catalent
The activist is pushing for a shake-up of the contract drug manufacturer’s board. Source link
Elliott Takes Big Stake in Drugmaker Catalent
The activist is pushing for a shake-up of the contract drug manufacturer’s board. Source link
Barclays Downgrades Catalent (CTLT) | Nasdaq
On April 3, 2023, Barclays downgraded their outlook for Catalent (NYSE:CTLT) from Overweight to Equal-Weight . Analyst Price Forecast Suggests 27.93% Upside As of March